Baxter International (BAX)
NYSEHealth CareMedical Instruments & SuppliesSnapshot 2026-07-07
$22.86+1.22%
Close 2026-07-07 · 1-day change
Reading BAX? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BAX free→NYSEHealth CareMedical Instruments & SuppliesSnapshot 2026-07-07
Reading BAX? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BAX free→QuarterlyIQ Insights · BAX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenues | 11,320.0 | 11,244.0 | 10,636.0 | 10,360.0 | 10,057.0 | 12,146.0 | 11,673.0 | 11,362.0 | 10,163.0 | 10,163.0 | 10,163.0 | 9,968.0 | 13,936.0 | 14,190.0 | 14,190.0 | 13,893.0 | 12,348.0 | 12,348.0 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 10,163.0 | 10,163.0 | 9,968.0 | 13,936.0 | 14,190.0 | 14,190.0 | 13,893.0 | 12,348.0 | 12,348.0 |
| Cost of Revenues | 7,911.0 | 7,865.0 | 6,652.0 | 6,210.0 | 6,508.0 | 7,426.0 | 7,086.0 | 6,601.0 | 6,047.0 | 6,053.0 | 6,053.0 | 5,822.0 | 6,802.0 | 6,889.0 | 6,889.0 | 6,847.0 | 6,218.0 | 6,218.0 |
| Gross Profit | 3,409.0 | 3,379.0 | 3,984.0 | 4,150.0 | 3,549.0 | 4,720.0 | 4,587.0 | 4,761.0 | 4,116.0 | 4,110.0 | 4,110.0 | 4,146.0 | 7,134.0 | 7,301.0 | 7,301.0 | 7,046.0 | 6,130.0 | 6,130.0 |
| Operating Expenses & Income | ||||||||||||||||||
| Selling, General & Admin | 2,915.0 | 2,890.0 | 2,967.0 | 2,953.0 | 3,097.0 | 2,845.0 | 2,469.0 | 2,535.0 | 2,725.0 | 2,739.0 | 2,739.0 | 3,094.0 | 3,283.0 | 3,324.0 | 3,324.0 | 3,154.0 | 2,698.0 | 2,698.0 |
| R&D Expenses | 517.0 | 518.0 | 590.0 | 518.0 | 450.0 | 531.0 | 521.0 | 595.0 | 646.0 | 647.0 | 647.0 | 603.0 | 1,081.0 | 1,156.0 | 1,156.0 | 946.0 | 868.0 | 868.0 |
| Other Operating Expenses, Total | 208.0 | 206.0 | 12.0 | 28.0 | (35.0) | 6.0 | 19.0 | 141.0 | — | — | — | — | — | — | — | — | — | — |
| Operating Income | (300.0) | (308.0) | 14.0 | 707.0 | (2,845.0) | 1,350.0 | 1,616.0 | 1,772.0 | 745.0 | 724.0 | 724.0 | 449.0 | — | — | — | — | — | — |
| Earnings from Continuing Operations | ||||||||||||||||||
| Interest Expense | — | 290.0 | 408.0 | 508.0 | 413.0 | 207.0 | 153.0 | 111.0 | 89.0 | 89.0 | 89.0 | 146.0 | 113.0 | 113.0 | 113.0 | 92.0 | 148.0 | — |
| Interest & Investment Income | — | 52.0 | 67.0 | 69.0 | 19.0 | 14.0 | 19.0 | 40.0 | 23.0 | 23.0 | 23.0 | 20.0 | 26.0 | 26.0 | 26.0 | 38.0 | 72.0 | — |
| Net Interest Expenses | — | 238.0 | 341.0 | 439.0 | 394.0 | 193.0 | 134.0 | 71.0 | 66.0 | 66.0 | 66.0 | 126.0 | 87.0 | 87.0 | 87.0 | 54.0 | 76.0 | — |
| Asset Writedown | — | — | — | — | — | — | — | — | — | — | — | — | — | 9.0 | 9.0 | — | — | — |
| EBT, Incl. Unusual Items | (508.0) | (505.0) | (289.0) | 242.0 | (3,248.0) | 1,116.0 | 1,292.0 | 970.0 | 4,954.0 | 4,954.0 | 4,954.0 | 428.0 | 2,838.0 | 2,889.0 | 2,889.0 | 2,809.0 | 2,462.0 | 2,462.0 |
| Income Tax Expense | 473.0 | 395.0 | 37.0 | 61.0 | (135.0) | 83.0 | 182.0 | (41.0) | (12.0) | (12.0) | (12.0) | 35.0 | 555.0 | 563.0 | 563.0 | 553.0 | 437.0 | 437.0 |
| Earnings from Continuing Operations | (981.0) | (900.0) | (326.0) | 181.0 | (3,113.0) | 1,033.0 | 1,110.0 | 1,011.0 | — | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||||
| Minority Interest | 0.0 | 0.0 | 11.0 | 7.0 | 12.0 | 11.0 | 8.0 | 10.0 | — | — | — | — | — | 32.0 | 32.0 | 32.0 | 11.0 | 11.0 |
| Net Income | (1,098.0) | (957.0) | (649.0) | 2,656.0 | (2,433.0) | 1,284.0 | 1,102.0 | 1,001.0 | 4,965.0 | 4,965.0 | 4,965.0 | 968.0 | 2,326.0 | 2,326.0 | 2,326.0 | 2,224.0 | 2,014.0 | 2,014.0 |
| Per Share | ||||||||||||||||||
| Basic EPS | (2.13) | (1.87) | (1.27) | 5.25 | (4.83) | 2.56 | 2.17 | 1.97 | 9.09 | 9.09 | 9.09 | 1.78 | 4.22 | 4.22 | 4.22 | 3.91 | 3.22 | 3.22 |
| Diluted EPS | (2.13) | (1.87) | (1.27) | 5.23 | (4.83) | 2.53 | 2.13 | 1.93 | 9.01 | 9.01 | 9.01 | 1.76 | 4.18 | 4.18 | 4.18 | 3.88 | 3.16 | 3.16 |
| Revenue per Share | 21.98 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | 0.52 | 1.04 | 1.16 | 1.15 | 1.09 | 0.96 | 0.85 | 0.51 | 0.51 | 0.51 | 1.27 | 1.57 | 1.57 | 1.57 | 1.27 | 0.91 | 0.91 |
| Basic Weighted Avg Shares | 515.0 | 513.0 | 510.0 | 506.0 | 504.0 | 502.0 | 509.0 | 509.0 | 546.0 | 546.0 | 546.0 | 545.0 | 551.0 | 551.0 | 551.0 | 569.0 | 625.0 | 625.0 |
| Diluted Weighted Avg Shares | 515.0 | 513.0 | 510.0 | 508.0 | 504.0 | 508.0 | 517.0 | 519.0 | 551.0 | 551.0 | 551.0 | 549.0 | 556.0 | 556.0 | 556.0 | 573.0 | 637.0 | 637.0 |
| Supplemental | ||||||||||||||||||
| EBITDA | — | 673.0 | 1,011.0 | 1,691.0 | (1,773.0) | 2,217.0 | 2,439.0 | 2,561.0 | 1,545.0 | 1,524.0 | 1,524.0 | 1,208.0 | — | — | — | — | — | — |
| EBIT | (300.0) | (308.0) | 14.0 | 707.0 | (2,845.0) | 1,350.0 | 1,616.0 | 1,772.0 | 745.0 | 724.0 | 724.0 | 449.0 | — | — | — | — | — | — |
| Effective Tax Rate | -93.1% | -78.2% | -12.8% | 25.2% | 4.2% | 7.4% | 14.1% | -4.2% | -0.2% | -0.2% | -0.2% | 8.2% | 19.6% | 19.5% | 19.5% | 19.7% | 17.7% | 17.7% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.